174 related articles for article (PubMed ID: 30787621)
1. Longdaysin inhibits Wnt/β-catenin signaling and exhibits antitumor activity against breast cancer.
Xiong Y; Zhou L; Su Z; Song J; Sun Q; Liu SS; Xia Y; Wang Z; Lu D
Onco Targets Ther; 2019; 12():993-1005. PubMed ID: 30787621
[TBL] [Abstract][Full Text] [Related]
2. Gigantol inhibits Wnt/β-catenin signaling and exhibits anticancer activity in breast cancer cells.
Yu S; Wang Z; Su Z; Song J; Zhou L; Sun Q; Liu S; Li S; Li Y; Wang M; Zhang GQ; Zhang X; Liu ZJ; Lu D
BMC Complement Altern Med; 2018 Feb; 18(1):59. PubMed ID: 29444668
[TBL] [Abstract][Full Text] [Related]
3. Transmembrane protein 97 exhibits oncogenic properties via enhancing LRP6-mediated Wnt signaling in breast cancer.
Zhu H; Su Z; Ning J; Zhou L; Tan L; Sayed S; Song J; Wang Z; Li H; Sun Q; Liu S; Sha O; Leng F; Chen X; Lu D
Cell Death Dis; 2021 Oct; 12(10):912. PubMed ID: 34615853
[TBL] [Abstract][Full Text] [Related]
4. Echinacoside inhibits breast cancer cells by suppressing the Wnt/β-catenin signaling pathway.
Tang C; Gong L; Lvzi Xu ; Qiu K; Zhang Z; Wan L
Biochem Biophys Res Commun; 2020 May; 526(1):170-175. PubMed ID: 32201078
[TBL] [Abstract][Full Text] [Related]
5. Rottlerin induces Wnt co-receptor LRP6 degradation and suppresses both Wnt/β-catenin and mTORC1 signaling in prostate and breast cancer cells.
Lu W; Lin C; Li Y
Cell Signal; 2014 Jun; 26(6):1303-9. PubMed ID: 24607787
[TBL] [Abstract][Full Text] [Related]
6. Prodigiosin inhibits Wnt/β-catenin signaling and exerts anticancer activity in breast cancer cells.
Wang Z; Li B; Zhou L; Yu S; Su Z; Song J; Sun Q; Sha O; Wang X; Jiang W; Willert K; Wei L; Carson DA; Lu D
Proc Natl Acad Sci U S A; 2016 Nov; 113(46):13150-13155. PubMed ID: 27799526
[TBL] [Abstract][Full Text] [Related]
7. The CK1δ/ε-AES axis regulates tumorigenesis and metastasis in colorectal cancer.
Wang Z; Zhou L; Wang Y; Peng Q; Li H; Zhang X; Su Z; Song J; Sun Q; Sayed S; Liu S; Lu D
Theranostics; 2021; 11(9):4421-4435. PubMed ID: 33754069
[No Abstract] [Full Text] [Related]
8. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S
Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851
[TBL] [Abstract][Full Text] [Related]
9. Hydroxytyrosol inhibits cancer stem cells and the metastatic capacity of triple-negative breast cancer cell lines by the simultaneous targeting of epithelial-to-mesenchymal transition, Wnt/β-catenin and TGFβ signaling pathways.
Cruz-Lozano M; González-González A; Marchal JA; Muñoz-Muela E; Molina MP; Cara FE; Brown AM; García-Rivas G; Hernández-Brenes C; Lorente JA; Sanchez-Rovira P; Chang JC; Granados-Principal S
Eur J Nutr; 2019 Dec; 58(8):3207-3219. PubMed ID: 30460610
[TBL] [Abstract][Full Text] [Related]
10. CDDO-Me Elicits Anti-Breast Cancer Activity by Targeting LRP6 and FZD7 Receptor Complex.
Zhou L; Wang Z; Yu S; Xiong Y; Fan J; Lyu Y; Su Z; Song J; Liu S; Sun Q; Lu D
J Pharmacol Exp Ther; 2020 Apr; 373(1):149-159. PubMed ID: 32015160
[TBL] [Abstract][Full Text] [Related]
11. Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt/β-catenin pathway.
Lu W; Lin C; Roberts MJ; Waud WR; Piazza GA; Li Y
PLoS One; 2011; 6(12):e29290. PubMed ID: 22195040
[TBL] [Abstract][Full Text] [Related]
12. The CK1δ/ϵ-Tip60 Axis Enhances Wnt/β-Catenin Signaling
Ning J; Sun Q; Su Z; Tan L; Tang Y; Sayed S; Li H; Xue VW; Liu S; Chen X; Lu D
Front Oncol; 2022; 12():844477. PubMed ID: 35494070
[TBL] [Abstract][Full Text] [Related]
13. Ganoderma lucidum (Reishi) suppresses proliferation and migration of breast cancer cells via inhibiting Wnt/β-catenin signaling.
Zhang Y
Biochem Biophys Res Commun; 2017 Jul; 488(4):679-684. PubMed ID: 28427938
[TBL] [Abstract][Full Text] [Related]
14. FL118, a novel camptothecin analogue, suppressed migration and invasion of human breast cancer cells by inhibiting epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.
Yang Z; Ji L; Jiang G; Liu R; Liu Z; Yang Y; Ma Q; Zhao H
Biosci Trends; 2018; 12(1):40-46. PubMed ID: 29553100
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer-specific mutations in CK1epsilon inhibit Wnt/beta-catenin and activate the Wnt/Rac1/JNK and NFAT pathways to decrease cell adhesion and promote cell migration.
Foldynová-Trantírková S; Sekyrová P; Tmejová K; Brumovská E; Bernatík O; Blankenfeldt W; Krejcí P; Kozubík A; Dolezal T; Trantírek L; Bryja V
Breast Cancer Res; 2010; 12(3):R30. PubMed ID: 20507565
[TBL] [Abstract][Full Text] [Related]
16. Silibinin inhibits Wnt/β-catenin signaling by suppressing Wnt co-receptor LRP6 expression in human prostate and breast cancer cells.
Lu W; Lin C; King TD; Chen H; Reynolds RC; Li Y
Cell Signal; 2012 Dec; 24(12):2291-6. PubMed ID: 22820499
[TBL] [Abstract][Full Text] [Related]
17. MiR-454-3p-Mediated Wnt/β-catenin Signaling Antagonists Suppression Promotes Breast Cancer Metastasis.
Ren L; Chen H; Song J; Chen X; Lin C; Zhang X; Hou N; Pan J; Zhou Z; Wang L; Huang D; Yang J; Liang Y; Li J; Huang H; Jiang L
Theranostics; 2019; 9(2):449-465. PubMed ID: 30809286
[TBL] [Abstract][Full Text] [Related]
18. IC261 induces cell cycle arrest and apoptosis of human cancer cells via CK1δ/ɛ and Wnt/β-catenin independent inhibition of mitotic spindle formation.
Cheong JK; Nguyen TH; Wang H; Tan P; Voorhoeve PM; Lee SH; Virshup DM
Oncogene; 2011 Jun; 30(22):2558-69. PubMed ID: 21258417
[TBL] [Abstract][Full Text] [Related]
19. Salinomycin exerts anti-colorectal cancer activity by targeting the β-catenin/T-cell factor complex.
Wang Z; Zhou L; Xiong Y; Yu S; Li H; Fan J; Li F; Su Z; Song J; Sun Q; Liu SS; Xia Y; Zhao L; Li S; Guo F; Huang P; Carson DA; Lu D
Br J Pharmacol; 2019 Sep; 176(17):3390-3406. PubMed ID: 31236922
[TBL] [Abstract][Full Text] [Related]
20. Tumor promoter TPA activates Wnt/β-catenin signaling in a casein kinase 1-dependent manner.
Su Z; Song J; Wang Z; Zhou L; Xia Y; Yu S; Sun Q; Liu SS; Zhao L; Li S; Wei L; Carson DA; Lu D
Proc Natl Acad Sci U S A; 2018 Aug; 115(32):E7522-E7531. PubMed ID: 30038030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]